Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

11.26USD
24 Mar 2017
Change (% chg)

$0.17 (+1.53%)
Prev Close
$11.09
Open
$11.47
Day's High
$11.48
Day's Low
$11.12
Volume
384,549
Avg. Vol
432,664
52-wk High
$11.71
52-wk Low
$3.91

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.19 December 25 Mar 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 3
(2) OUTPERFORM 1 1 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.20 1.20 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 3 3.99 4.77 3.40 19.50
Quarter Ending Jun-17 3 4.90 5.70 4.30 9.10
Year Ending Dec-17 4 32.28 51.53 20.50 79.21
Year Ending Dec-18 4 104.44 140.25 59.70 96.43
Earnings (per share)
Quarter Ending Mar-17 3 -0.19 -0.18 -0.21 --
Quarter Ending Jun-17 3 -0.18 -0.17 -0.21 --
Year Ending Dec-17 4 -0.60 -0.30 -0.82 0.33
Year Ending Dec-18 4 -0.01 0.63 -0.56 0.75

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 4.44 4.65 0.21 4.75
Quarter Ending Sep-16 52.90 53.85 0.95 1.80
Quarter Ending Jun-16 6.32 8.48 2.15 34.01
Quarter Ending Mar-16 3.27 2.45 0.82 25.07
Quarter Ending Dec-15 2.25 5.09 2.84 126.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 3.99 3.99 3.90 3.90 19.50
Quarter Ending Jun-17 4.90 4.90 5.10 5.10 9.10
Year Ending Dec-17 32.28 38.04 43.34 43.34 79.21
Year Ending Dec-18 104.44 104.44 103.33 103.33 96.43

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 0 1
Quarter Ending Jun-17 0 0 0 1
Year Ending Dec-17 0 0 0 3
Year Ending Dec-18 0 0 1 1
Earnings

More From Around the Web